Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
about
The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challengesA Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous SystemsFrom gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionAngiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation.ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.Role of the renin-angiotensin system, renal sympathetic nerve system, and oxidative stress in chronic foot shock-induced hypertension in rats.Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.Adipokines, diabetes and atherosclerosis: an inflammatory association.Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice.Inhibition of PDE5 Restores Depressed Baroreflex Sensitivity in Renovascular Hypertensive RatsAngiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependenceRole of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureUpdate on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.Association study of angiotensin converting enzyme gene polymorphism with elderly diabetic hypertension and lipids levels.Increased Apoptosis in the Paraventricular Nucleus Mediated by AT1R/Ras/ERK1/2 Signaling Results in Sympathetic Hyperactivity and Renovascular Hypertension in Rats after Kidney Injury.Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/ angiotensin-(1-7) axis in ratsInsufficient hypothalamic angiotensin-converting enzyme 2 is associated with hypertension in SHR rats.Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension.Protective axis of the renin-angiotensin system in the brain.Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension.Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring.DOCA-Salt Hypertension: an Update.Rapid metabolism of exogenous angiotensin II by catecholaminergic neuronal cells in culture media.The effect of angiotensin II microinjection into the bed nucleus of the stria terminalis on serum lipid peroxidation and nitric oxide metabolite levels.Effects of female sex hormones on expression of the Ang-(1-7)/Mas-R/nNOS pathways in rat brain.Protein Kinase C-δ Mediates Shedding of Angiotensin-Converting Enzyme 2 from Proximal Tubular Cells.High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice.Angiotensin-(1-7) in Paraventricular Nucleus Contributes to the Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activity in Chronic Heart Failure Rats.Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites.Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms.Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke.Forkhead Box Transcription Factors of the FOXA Class Are Required for Basal Transcription of Angiotensin-Converting Enzyme 2.
P2860
Q26823573-4E3FCA43-D43A-4C61-BA30-2589328860BAQ28072451-17928365-473C-4EBC-A25E-D070CBCC1822Q33795353-EEC8AF80-EF69-4898-9C91-DDE650BCB6CEQ34510691-4E9CA953-5395-4D72-BF44-59F65A7CC6EEQ34972079-67242E29-A090-49A9-903E-BC7C2B52B034Q35079417-27FD78C0-6180-4B85-B53C-25726A5FB601Q35138448-27853FA7-0A7A-418B-A660-A2A2CAEB188AQ35138558-51BE59F9-E559-439D-AA3D-4EB2067047E1Q35632723-2E94582C-7768-4966-9052-66E86307B7AAQ35738095-9103D4C1-1A75-4914-9291-E6E7452505FDQ35990719-051426AB-C208-497F-A725-83D743569F67Q36114331-16EE693F-0B15-403D-B843-80FC6311BB83Q36241112-4D04C67A-7B89-4D74-8B25-B009FFFB1EDCQ36305106-A31A53B2-749F-490E-9625-BF0A9CE1447EQ36511251-FD37FFC0-91EC-4BCA-8748-64A9065947BAQ36825182-C8FFEDB5-7B84-4685-A22D-D91C7EE75C16Q37081415-593B3317-9662-4523-AA59-88135A583B1DQ37454928-DE7DEDB4-55D6-474B-ADC2-114FF25AD9F3Q37497201-500C3CB3-C20C-4E21-8FCF-2A4C293F0DC2Q37620005-6528D5B6-5599-4C7E-B009-31D01BE0A88BQ37730259-F6A5E09B-AD63-41F1-906A-51CF63F6B9BFQ37746299-EE7AD03C-7660-4D1B-A5C2-31BAFE0D21CEQ38205300-7815DE44-4DFB-40CB-AFBD-191022B493F7Q38211744-1AD67E83-496D-4702-881C-C5229616E570Q38781945-6CA61C7F-C347-4DEC-8E08-FA2E67D5A76AQ38800189-FDE04BD5-8A26-4F25-900B-02B881EE9491Q39206260-E9603F87-352C-4058-A17A-139E9623F993Q39509292-91BE978D-BD37-45E7-8428-302139C1076AQ39634108-D3111EB9-BC90-4390-AB16-C0272DAE9008Q40406847-0A376F5A-7336-4134-A663-D2C88C925407Q42494833-598C6620-7598-4741-BE12-30850C61B760Q45848259-9F7A4037-5674-4333-A2E4-EAE5859E4DFFQ47259267-9255F864-A63B-40A6-B983-F658535F7EB7Q47643112-1C652235-8503-4A61-9C22-6F796CEE3165Q47644016-F5241BEC-1E29-448D-8268-4CBEB3BF9924Q48589407-2E1E2EBD-6B2B-4DB6-9D9B-7D956B8038CBQ52863071-F8AE7233-A1AA-4253-B582-8A27D06186D8
P2860
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@ast
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@en
type
label
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@ast
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@en
prefLabel
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@ast
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@en
P2093
P2860
P1433
P1476
Brain angiotensin-converting e ...... nt of neurogenic hypertension.
@en
P2093
Eric Lazartigues
Huijing Xia
Kavaljit H Chhabra
P2860
P304
P356
10.1161/CIRCRESAHA.113.301811
P577
2013-09-06T00:00:00Z